Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancersMichael Pourdehnad, Davide Ruggero, Morgan Truitt et al.|Proceedings of the National Academy of Sciences|2013Cited by 297
The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profileBeatrice T. Wang, Kevan M. Shokat, Gregory S. Ducker et al.|Proceedings of the National Academy of Sciences|2011Cited by 111
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsGregory S. Ducker, Robert S. Warren, Chloé E. Atreya et al.|Oncogene|2013Cited by 92
Microprotein SMIM26 drives oxidative metabolism via serine-responsive mitochondrial translationJie Min Nah, Lena Ho, Sonia Chothani et al.|Molecular Cell|2025Cited by 8
Primary resistance to ATP-competitive mTOR inhibitors for the treatment of solid tumorsGregory S. Ducker|France Medecine|2013Cited by 0